Rigel Pharmaceuticals
Rigel Pharmaceuticals develops innovative therapies for hematologic disorders and cancers, including TAVALISSE®, REZLIDHIA®, and GAVRETO®.
Specifications
- LocationCalifornia, USA
- Industry Role
- Colors

Rigel Pharmaceuticals develops innovative therapies for hematologic disorders and cancers, including TAVALISSE®, REZLIDHIA®, and GAVRETO®.
